Transcranial Direct Current Stimulation for Pediatric OCD
Trial Summary
What is the purpose of this trial?
This trial is testing tDCS, a method using a small electrical current on the scalp, in children with OCD. The goal is to see if it can help normalize their brain function and improve symptoms. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that has been extensively investigated in adults with psychiatric disorders, including depression and anxiety.
Do I have to stop taking my current medications for the trial?
The trial requires that your current medications remain stable during the study. If you are on psychotropic medications, they must not have changed within 8 weeks before the study (6 weeks for antipsychotics). You cannot start new antidepressants within 12 weeks or new antipsychotics within 6 weeks before the study. Any changes due to side effects will be discussed with the study psychiatrist.
Will I have to stop taking my current medications?
The trial requires that any current medications must remain stable during the study. If you are on psychotropic medications, they should not have changed within 8 weeks before joining the study (6 weeks for antipsychotics).
What data supports the idea that Transcranial Direct Current Stimulation for Pediatric OCD is an effective treatment?
The available research shows that Transcranial Direct Current Stimulation (tDCS) may help reduce symptoms in patients with treatment-resistant OCD. Although the studies are limited and vary in how they apply the treatment, some patients have experienced improvements in OCD symptoms, as well as in related issues like depression and anxiety. However, more research is needed to confirm these findings, as there are no studies that compare tDCS to a placebo treatment.12345
What data supports the effectiveness of the treatment Transcranial Direct Current Stimulation (tDCS) for Pediatric OCD?
Research suggests that tDCS, a treatment using a mild electrical current to influence brain activity, may help reduce symptoms of OCD, depression, and anxiety in patients who haven't responded to other treatments. However, more studies are needed to confirm these findings, as current evidence is limited and lacks rigorous control.12345
What safety data exists for tDCS in children?
Existing safety data for transcranial direct current stimulation (tDCS) in children is limited but suggests it is generally safe and tolerable. Studies report minor side effects such as tingling, itching, mood changes, and irritability. Systematic reviews indicate that adverse events are low and transient, but more research is needed to confirm long-term safety, especially considering the developing brain.678910
Is transcranial direct current stimulation (tDCS) safe for children?
Transcranial direct current stimulation (tDCS) is generally considered safe and well-tolerated in children, with common side effects being mild, such as tingling, itching, mood changes, and irritability. However, more research is needed to fully understand its long-term safety in young people.678910
Is Transcranial Direct Current Stimulation (tDCS) a promising treatment for Pediatric OCD?
Transcranial Direct Current Stimulation (tDCS) is a promising treatment for Pediatric OCD because it is a non-invasive method that can help reduce symptoms and improve cognitive function in children and adolescents. It is well-tolerated, meaning most kids can handle it without problems, and early studies show it might be safe and effective for young people with psychiatric disorders.1011121314
How is transcranial direct current stimulation (tDCS) different from other treatments for pediatric OCD?
Transcranial direct current stimulation (tDCS) is unique because it is a non-invasive treatment that uses a weak electric current applied to the scalp to modulate brain activity, unlike traditional medications or therapies. It is still being researched for its effects on the developing brain, but early studies suggest it is safe and well-tolerated in children and adolescents.1011121314
Research Team
Joan Camprodon, MD, MPH, PhD
Principal Investigator
Massachusetts General Hospital
Daniel Geller, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for kids aged 10-17 with moderate to severe OCD, as measured by a specific scale. They must have an IQ of at least 85 and speak English. Kids can't join if they've had recent medication changes, certain mental health diagnoses, are underweight, pregnant or nursing, or have metal implants in the head/neck.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo three sessions of tDCS: two active sessions and one sham session, with the order randomized.
Follow-up
Participants are monitored for changes in neurocognitive processes after tDCS sessions.
Treatment Details
Interventions
- Transcranial Direct Current Stimulation (tDCS)
Transcranial Direct Current Stimulation (tDCS) is already approved in United States, European Union, Canada for the following indications:
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
- Depression
- Stroke rehabilitation
- Chronic pain management
- Research use for various neurological and psychiatric conditions including autism spectrum disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor